MDxHealth SA ADR (MDXH) Live Share Price, Invest From India

MDxHealth SA ADR Stock Performance

as on May 2, 2026 at 6:57 am IST

Day's Low
Day's High
$2.04
Day's Price Range
$2.08
$2.06
0.97%
Downside
0.97%
Upside
52 Week's Low
52 Week's High
$1.67
52-Week Price Range
$5.33
$2.06
18.93%
Downside
158.74%
Upside

MDxHealth SA ADR share price movements today

Previous Close: $2.04
Open: $2.06
Volume: 391.0K
Day's Low - High: $2.04 - $2.08
52 Week Low - High: $1.67 - $5.33

MDxHealth SA ADR Historical Returns

1 Month Return: -4.63 %
3 Month Return: -41.64 %
1 Year Return: + 19.77 %
3 Year Return: -41.64 %
5 Year Return: 0 %

MDxHealth SA ADR Stock Fundamentals & Key Indicators

Check MDxHealth SA ADR market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$104.8M

EPS (TTM)

-0.32

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-7.1M

Revenue (TTM)

107.9M

Profit Margin

-31.07%

Return On Equity TTM

-2440.41%

MDxHealth SA ADR vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of MDxHealth SA ADR with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
MDxHealth SA ADR	BUY	$104.8M	NA	NA	-31.07%
IDEXX Laboratories Inc	BUY	$44.7B	3.36%	42.91	24.62%
Thermo Fisher Scientific Inc	BUY	$178.0B	-0.22%	26.32	15.15%
Agilent Technologies Inc	BUY	$32.4B	-14.31%	25.28	18.26%
Danaher Corporation	BUY	$126.7B	-31.03%	34.75	14.89%

Stock Returns calculator for MDxHealth SA ADR Stock including INR - Dollar returns

The MDxHealth SA ADR stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

MDxHealth SA ADR investment value today

Current value as on today

₹1,34,480

Returns

₹34,480

(+34.48%)

Returns from MDxHealth SA ADR Stock

₹19,767 (+19.77%)

Dollar Impact

₹14,713 (+14.71%)

Analyst Recommendation on MDxHealth SA ADR Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for MDxHealth SA ADR. Average target price of $7.4

MDxHealth SA ADR Share Price Target

Get share price movements and forecasts by analysts on MDxHealth SA ADR.

What analysts predicted

72.16%UPSIDE

Target Price

$7.4

Current Price

$2.06

Analyzed by

12 Analysts

Target

$7.40

MDxHealth SA ADR target price $7.4, a slight upside of 72.16% compared to current price of $2.06. According to 12 analysts rating.

MDxHealth SA ADR Stock’s Investor Sentiment and Interest

Search interest for MDxHealth SA ADR Stock has increased by 33% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 3, 2026 to May 3, 2026

Change:33% versus previous 30 day period

MDxHealth SA ADR Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	38	19	41	23	48	24	53	27	54	54
Gross Profit	25	12	25	14	29	15	35	17	29	29
Operating Income	-10	-6	-14	-6	-10	-4	-3	-2	-11	-11
EBITDA	-17	-3	-8	-3	-6	-1	0	0	-6	-6
Interest Expense	10	3	4	4	7	5	12	5	8	8
Depreciation	1	1	1	2	2	2	2	2	2	-
Income Before Tax	-20	-8	-20	-10	-17	-9	-15	-8	-19	-19
Income Tax Expense	0	0	-	0	0	0	0	0	-1	-1
Net Income	-20	-8	-20	-11	-18	-9	-14	-8	-18	-18
Net Profit Margin	-53.59%	-42.91%	-47.72%	-47.99%	-37.52%	-37.91%	-27.71%	-29.20%	-34.35%	-34.35%

MDxHealth SA ADR Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	29	40	28	11	18	22	37	70	90	107
Gross Profit	19	30	16	0	8	10	19	43	55	64
Operating Income	-12	-12	-32	-43	-27	-26	-37	-27	-24	-15
EBITDA	-11	-10	-29	-39	-23	-24	-36	-30	-22	-6
Interest Expense	0	0	0	0	1	1	2	5	7	12
Depreciation	-	1	2	3	3	3	4	7	8	9
Income Before Tax	-13	-12	-32	-43	-28	-29	-44	-43	-37	-35
Income Tax Expense	0	0	0	0	1	1	6	0	0	-1
Net Income	-13	-12	-32	-43	-28	-29	-44	-43	-38	-33
Net Profit Margin	-44.11%	-30.33%	-114.51%	-365.72%	-155.27%	-130.41%	-118.86%	-61.40%	-42.28%	-31.07%

MDxHealth SA ADR Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-6	-14	-6	-10	-4	-3	-8	-29	-29
Operating Cash Flow	-5	-9	-5	-8	-2	-1	1	-8	0
Investing Cash Flow	0	-1	0	0	0	-19	0	0	1
Financing Cash Flow	-1	10	33	34	21	-11	-1	24	-5
Change in Cash	-7	6	27	-2	18	-32	0	-3	-2

MDxHealth SA ADR Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-12	-32	-43	-27	-26	-37	-27	-24	-33
Operating Cash Flow	-10	-28	-22	-20	-22	-34	-21	-18	-10
Investing Cash Flow	-6	-1	0	0	0	-29	-3	-1	-20
Financing Cash Flow	0	41	17	14	66	20	32	44	12
Change in Cash	-14	9	-4	-6	42	-42	6	24	-17

Global Institutional Holdings in MDxHealth SA ADR

Funds	Holdings
Rhumbline Advisers	0%
Marshall Wace Asset Management Ltd	0.08%
Marshall Wace Asset Management Ltd	0%
Rhumbline Advisers	0%

Insights on MDxHealth SA ADR

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 27.43M → 54.66M (in $), with an average increase of 24.9% per quarter
NO EFFECT
Against Peers
In the last 3 years, IDEXX Laboratories, Inc. has given 18.5% return, outperforming this stock by 63.1%
NO EFFECT
Against Peers
In the last 1 year, IDEXX Laboratories, Inc. has given 20.3% return, outperforming this stock by 0.5%
NEGATIVE IMPACT
Price Dip
In the last 3 months, MDXH stock has moved down by -42.8%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -8.01M → -18.77M (in $), with an average decrease of 67.2% per quarter

About MDxHealth SA ADR

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolve mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection. It also offers genomic prostate score, which provides personalized genomic insights to physicians and patients navigating the complexities of prostate cancer diagnosis and treatment. The company sells its products through urology sales force consisting of direct sales representatives, strategic account managers, and regional sales managers. The company has a collaboration with the University of Oxford: the initiation of Genomic Prostate Score (GPS) testing in the landmark UK ProtecT trial (Prostate Testing for Cancer and Treatment). The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

Organisation	MDxHealth SA ADR
Headquarters	CAP Business Center, Herstal, Belgium, 4040
Industry	Diagnostics & Research
CEO	Mr. Michael K. McGarrity
E-voting on shares	Click here to vote

Key Management of MDxHealth SA ADR

Name	Title
Ms. Kim Leroux	Executive Vice President of Revenue Cycle Management
Mr. Michael K. McGarrity	CEO & Executive Director
Mr. Ron Kalfus CPA	Interim Chief Financial Officer
Mr. Joseph Sollee J.D., LLM	Executive VP of Corporate Development & General Counsel
Mr. John A. Bellano	Chief Commercial Officer
Mr. Scott McMahan	Vice President of Finance & Accounting

FAQs

What is MDxHealth SA ADR share price today?

MDxHealth SA ADR share price today is $2.06 as on May 2, 2026 at 1:27 am IST at the close of the market. MDxHealth SA ADR share today touched a day high of $2.08 and a low of $2.04.

What is the 52 week high and 52 week low for MDxHealth SA ADR share?

MDxHealth SA ADR share touched a 52 week high of $5.33 on October 28, 2025 and a 52 week low of $1.67 on May 5, 2025. MDxHealth SA ADR stock price today i.e. May 2, 2026 at 1:27 am IST is closed at $2.06,which is 61.35% down from its 52 week high and 23.35% up from its 52 week low.

What is MDxHealth SA ADR's market capitalisation today?

MDxHealth SA ADR market capitalisation is $0.00T as on May 2, 2026 at 1:27 am IST.

How to invest in MDxHealth SA ADR Stock (MDXH) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for MDxHealth SA ADR on INDmoney app. Click on Buy button. You can invest as low as $1.5 in MDxHealth SA ADR Shares that will get you 0.7282 shares as per MDxHealth SA ADR share price of $2.06 per share as on May 2, 2026 at 1:27 am IST.

What is the minimum amount required to buy MDxHealth SA ADR Stock (MDXH) from India?

Indian investors can start investing in MDxHealth SA ADR (MDXH) shares with as little as ₹94.91 or $1 (as of May 3, 2026 at 8:44 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.10 in MDxHealth SA ADR stock (as per the Rupee-Dollar exchange rate as on May 3, 2026 at 8:44 am IST). Based on MDxHealth SA ADR share’s latest price of $2.06 as on May 2, 2026 at 1:27 am IST, you will get 4.8544 shares of MDxHealth SA ADR. Learn more about fractional shares .